標(biāo)題: Titlebook: Interventional Therapies for Secondary and Essential Hypertension; Costas Tsioufis,Roland E. Schmieder,Giuseppe Manci Book 2016 Springer I [打印本頁] 作者: Stimulant 時(shí)間: 2025-3-21 16:04
書目名稱Interventional Therapies for Secondary and Essential Hypertension影響因子(影響力)
書目名稱Interventional Therapies for Secondary and Essential Hypertension影響因子(影響力)學(xué)科排名
書目名稱Interventional Therapies for Secondary and Essential Hypertension網(wǎng)絡(luò)公開度
書目名稱Interventional Therapies for Secondary and Essential Hypertension網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Interventional Therapies for Secondary and Essential Hypertension被引頻次
書目名稱Interventional Therapies for Secondary and Essential Hypertension被引頻次學(xué)科排名
書目名稱Interventional Therapies for Secondary and Essential Hypertension年度引用
書目名稱Interventional Therapies for Secondary and Essential Hypertension年度引用學(xué)科排名
書目名稱Interventional Therapies for Secondary and Essential Hypertension讀者反饋
書目名稱Interventional Therapies for Secondary and Essential Hypertension讀者反饋學(xué)科排名
作者: 假裝是你 時(shí)間: 2025-3-21 21:31 作者: FLAGR 時(shí)間: 2025-3-22 03:48
Thomas Zeller MD,Ulrich Beschorner MD,Elias Noory MD作者: 導(dǎo)師 時(shí)間: 2025-3-22 06:13
Maria Boutsikou MD, MSc, PhD,Anselm Uebing MD, PhD,Michael A. Gatzoulis MD, PhD, FACC, FESC作者: 吊胃口 時(shí)間: 2025-3-22 11:13 作者: 打火石 時(shí)間: 2025-3-22 13:07
Atul Pathak MD, Phd,Benjamin Honton MD,Mel Lobo MD作者: 吹牛需要藝術(shù) 時(shí)間: 2025-3-22 18:28 作者: 令人不快 時(shí)間: 2025-3-22 23:00 作者: Palliation 時(shí)間: 2025-3-23 04:35
Interventions for Renovascular Hypertensioned trials could prove a benefit of RAS revascularization compared to medical management. These negative trials including the CORAL trial had significant flaws in study design; crucial for a clinical benefit of revascularization of RAS is a proper patient selection, revascularization is only indicate作者: Acetabulum 時(shí)間: 2025-3-23 07:27 作者: hangdog 時(shí)間: 2025-3-23 11:33
Sleep Apnealood pressure monitoring (ABPM) in the confirmation of HTN in subjects with OSAS and whether the proper identification and management of OSAS in subjects with resistant HTN will improve BP control. Particular emphasis will be put on the role of CPAP ventilation for the treatment of OSAS, which is kn作者: audiologist 時(shí)間: 2025-3-23 17:21 作者: 臨時(shí)抱佛腳 時(shí)間: 2025-3-23 19:55
Blood Pressure Measurement Before and After Interventionof differences among hours, minutes, and even adjacent beats. They also show variations over more prolonged periods because of differences among days, months, and season [1]. Even though it has been discussed, the prognostic relevance of the different kinds of variability in the case of resistant hy作者: SEMI 時(shí)間: 2025-3-24 01:10
Novel Drugs in the Treatment of Hypertensiond Trial of Intensive versus Standard Blood-Pressure Control (SPRINT) [2]. In addition, further drugs including mineralocorticoid receptor (MR) antagonists, amiloride, and the alpha-1-blocker doxazosin are available for treatment of patients with resistant hypertension [1]. Nevertheless, there is sti作者: 拋物線 時(shí)間: 2025-3-24 06:07 作者: 確認(rèn) 時(shí)間: 2025-3-24 10:13
Mónica Domenech MD, PhD,Antonio Coca MD, PhD, FRCP, FESCFilze mit ganz spezi- fischen Eigenschaften herzustellen. Künstliche Eiwei?fasern (Kasein- Erdnu?- und Maiseiwei?fasern) sind vor allem in der Hutindustrie in Zeiten gefragt, in welchen die Preise für die Rohstoffe stark ansteigen. Hinzu kommt noch, da? die Beimengung derartiger Fasern zu Wolle, Kanin- oder H978-3-663-03602-9978-3-663-04791-9作者: employor 時(shí)間: 2025-3-24 11:19
Enrico Agabiti Rosei,Massimo SalvettiFilze mit ganz spezi- fischen Eigenschaften herzustellen. Künstliche Eiwei?fasern (Kasein- Erdnu?- und Maiseiwei?fasern) sind vor allem in der Hutindustrie in Zeiten gefragt, in welchen die Preise für die Rohstoffe stark ansteigen. Hinzu kommt noch, da? die Beimengung derartiger Fasern zu Wolle, Kanin- oder H978-3-663-03602-9978-3-663-04791-9作者: 法律 時(shí)間: 2025-3-24 16:03
Ina Zivanovic,Sebastian Ewen,Michael B?hm,Felix Mahfoud MD, FESCrauchs in NRW bis zum Jahr 2000 vorausgesch?tzt. Die Methodik besteht in der Trendextrapolation der ?konomischen Faktoren, die als erkl?rende Gr??en den Endenergieverbrauch bestimmten, wobei Querschnittsanalysen und Informationen anderer Bundesl?nder und des Auslands verarbeitet wurden, einerseits u作者: 氣候 時(shí)間: 2025-3-24 19:07 作者: LIEN 時(shí)間: 2025-3-24 23:34
Reinhold Kreutz,Engi Abdel-Hady Algharablyen aufgegriffen und diskutiert. Die Ergebnisse zeigen, dass sich elektronische überwachung prinzipiell positiv auf die Lebensqualit?t Betroffener auswirken kann978-3-658-35803-7978-3-658-35804-4Series ISSN 2625-1515 Series E-ISSN 2625-1523 作者: gonioscopy 時(shí)間: 2025-3-25 05:31 作者: CHURL 時(shí)間: 2025-3-25 07:47 作者: 規(guī)章 時(shí)間: 2025-3-25 13:25
Interventions for Renovascular Hypertensionomes. Main etiologies of RAS are atherosclerosis (approximately 90?%) and fibromuscular dysplasia (FMD). Atherosclerotic RAS has a considerable overlap with atherosclerotic manifestation elsewhere and is associated with an overall poor prognosis. Technical improvements of diagnostic and intervention作者: sinoatrial-node 時(shí)間: 2025-3-25 16:34 作者: Control-Group 時(shí)間: 2025-3-25 22:50
Pheochromocytoma/Paragangliomasrenal glands. Chromaffin tumors arising from extra-adrenal autonomic paraganglia are called paragangliomas. Paragangliomas of parasympathetic origin develop from non-chromaffin organs that act as chemoreceptors. Malignant tumors occur in about 10?% pheochromocytomas, the others are benign. The diagn作者: LUCY 時(shí)間: 2025-3-26 03:07
Coarctation of the Aorta?% of all congenital heart disease, and the condition is 1.7 times more frequent in white males than white females [2]. Aortic coarctation can present as a localised discrete stenosis of the aortic isthmus, but segmental tubular hypoplasia of the aortic arch is also commonly associated. The usual si作者: MAL 時(shí)間: 2025-3-26 07:07 作者: ALLEY 時(shí)間: 2025-3-26 11:12
The Impact of Uncontrolled Hypertension on the Cerebrovascular Systems. However, one of the most important unresolved questions is how far blood pressure should be lowered to prevent the first stroke and recurrences. Most available data comes from post hoc analyses of clinical trials on the prevention of morbidity and mortality. The European Society of Hypertension a作者: epicondylitis 時(shí)間: 2025-3-26 12:43 作者: 老巫婆 時(shí)間: 2025-3-26 17:21
Optimization of Antihypertensive Drug Treatment in Resistant Hypertensiono effectively lower the elevated blood pressure (BP) values, hopefully leading the patient’s status to BP control (<140/90 mmHg). Although invasive procedures such as renal denervation and carotid baroreflex stimulation can achieve this goal in a number of patients, there is no question that the fir作者: 幾何學(xué)家 時(shí)間: 2025-3-26 21:19
Blood Pressure Measurement Before and After Interventionnosis about the real “resistance” to the antihypertensive treatment given, and it is defined when a therapeutic strategy that includes appropriate lifestyle measures plus a diuretic and two other antihypertensive drugs belonging to different classes at adequate doses fails to lower systolic blood pr作者: backdrop 時(shí)間: 2025-3-27 01:54
Novel Drugs in the Treatment of Hypertension. The recent European guidelines of the European Society of Hypertension and the European Society of Cardiology for the management of HTN recommend with class I and evidence level A the use of diuretics (including thiazides, chlorthalidone, and indapamide), beta-blockers, calcium antagonists, angiot作者: covert 時(shí)間: 2025-3-27 06:53
Adherence to Medications in Uncontrolled Hypertensionlity in hypertensive patients and to decrease the risk of developing cardiac, renal, and neurological complications [1–3]. Today, the clinical management of essential HTN is based essentially on the recommendation of lifestyle changes such as losing weight, eating less salt or exercising more, and o作者: 大門在匯總 時(shí)間: 2025-3-27 09:51
Pathophysiology of Renal Sympathetic Denervation (RSDN) also prognosis of most cardiometabolic disorders (chronic heart failure or kidney disease, coronary heart disease, obesity, diabetes, etc.), among them hypertension (HTN). This has been established through studies recording SNS activation at systemic and local levels using different techniques to m作者: 清楚說話 時(shí)間: 2025-3-27 16:51 作者: 召集 時(shí)間: 2025-3-27 20:50
Procedural Aspects of Renal Sympathetic Denervationnervous system. In recent years, several procedural advancements have been made. The distribution of sympathetic nerves in the relation to the renal arteries has been further analyzed. The impact of different lesion sites, lesion numbers, and patterns has been evaluated. The spectrum of denervation 作者: Demonstrate 時(shí)間: 2025-3-27 23:57 作者: 出價(jià) 時(shí)間: 2025-3-28 05:49 作者: Classify 時(shí)間: 2025-3-28 09:33 作者: 鞭子 時(shí)間: 2025-3-28 10:47 作者: FEIGN 時(shí)間: 2025-3-28 16:17
Enrico Agabiti Rosei,Massimo Salvetti. auf rüttelartig bewegten Walzen oder Platten, erhalten werden. Hierbei verflechten und verschlingen sich die Haare zu einem Gebilde von mehr oder weniger hoher Festigkeit, das als fadenloser Filz, im Gegensatz zu den gewebten, gewirkten und gestrickten Filzen bezeichnet wird. Die Eigenschaft unter作者: 托人看管 時(shí)間: 2025-3-28 21:23
Reinhold Kreutz,Engi Abdel-Hady Algharably Hintergrund des demografischen Wandels und der damit verbundenen Herausforderungen ist die Integration technischer Innovationen ins Pflegesystem nicht selbstverst?ndlich als erstrebenswert zu erachten. Vielmehr ist der sowohl hierzulande als auch international zur Bew?ltigung der Herausforderungen 作者: 潔凈 時(shí)間: 2025-3-28 23:51 作者: Negotiate 時(shí)間: 2025-3-29 03:41 作者: Exposition 時(shí)間: 2025-3-29 10:27 作者: nutrients 時(shí)間: 2025-3-29 14:54
Costas Tsioufis,Roland E. Schmieder,Giuseppe ManciFocuses solely on interventional treatments of hypertension (secondary and essential).Offers a clear review of relevant procedures and guidance on their applications.Includes helpful explanatory diagr作者: 防水 時(shí)間: 2025-3-29 18:15
Updates in Hypertension and Cardiovascular Protectionhttp://image.papertrans.cn/i/image/472988.jpg作者: Subdue 時(shí)間: 2025-3-29 22:17
https://doi.org/10.1007/978-3-319-34141-5Resistant hypertension; Secondary hypertension; Renal artery stenosis; Hyperaldosteronism; Pheochromocyt作者: CHAR 時(shí)間: 2025-3-30 01:43 作者: 使尷尬 時(shí)間: 2025-3-30 07:58 作者: 倔強(qiáng)不能 時(shí)間: 2025-3-30 12:03
Pathophysiology of Renal Sympathetic Denervation (RSDN)em hypertension (HTN). This has been established through studies recording SNS activation at systemic and local levels using different techniques to measure SNS outflow to various organs. Mechanisms leading to SNS activation are heterogeneous varying from central activation to reflex-mediated sympathoexcitation (or lack of sympathoinhibition).作者: 消耗 時(shí)間: 2025-3-30 12:44 作者: Largess 時(shí)間: 2025-3-30 19:47
Primary Aldosteronism: A Field on the Movemagnitude of the problem; to critically discuss available tests for the screening, confirmation, and lateralization of primary aldosteronism; to present the therapeutic options; and to propose a simple algorithm for the diagnosis and management of primary aldosteronism.作者: 即席演說 時(shí)間: 2025-3-30 21:18
2366-4606 nce on their applications.Includes helpful explanatory diagr.This book aims to describe the role of interventional therapies in various forms of secondary hypertension and to explain the ability of such approaches to address unmet needs in the setting of uncontrolled essential hypertension. The cove作者: collateral 時(shí)間: 2025-3-31 01:05 作者: CRANK 時(shí)間: 2025-3-31 08:42
